For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241203:nRSC5008Oa&default-theme=true
RNS Number : 5008O Spire Healthcare Group PLC 03 December 2024
3 December 2024
Spire Healthcare Group plc
Transaction in own shares
Spire Healthcare Group plc (the "Company") announces that, in accordance with
the terms of its share buyback programme announced on 31 October 2024 (the
"Share Buyback Programme") and the authority granted by its shareholders at
the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased
the following number of its ordinary shares of 1 pence each ("Shares") on the
London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):
Date of purchase: 2 December 2024
Number of Shares purchased: 17,444
Highest price paid per Share (GBp): 226.50
Lowest price paid per Share (GBp): 225.00
Volume weighted average price paid per Share (GBp): 225.7434
Broker: Deutsche Numis
Trading venue: London Stock Exchange
The purchased Shares will be cancelled.
Following the purchase of these Shares, the remaining number of Shares in
issue will be 403,097,028. The Company does not hold any Shares in treasury.
Therefore, the total number of voting rights in the Company is 403,097,028.
This figure may be used by shareholders as the denominator for the calculation
by which they can determine if they are required to notify their interest in,
or a change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms
part of domestic law of the United Kingdom by virtue of the European Union
(Withdrawal) Act 2018, the table below contains detailed information of the
individual trades made by Deutsche Numis as part of the Share Buyback
Programme:
Date of purchase Number of ordinary shares purchased Transaction price Time of transaction (UK Time) Transaction reference number Trading venue
(GBp share)
2 December 2024 2511 225.50 08:29:53 00072652403TRLO0 XLON
2 December 2024 2420 225.00 08:29:55 00072652409TRLO0 XLON
2 December 2024 230 225.00 08:33:49 00072652512TRLO0 XLON
2 December 2024 500 225.50 08:48:39 00072652886TRLO0 XLON
2 December 2024 552 225.50 08:49:02 00072652916TRLO0 XLON
2 December 2024 300 225.50 08:49:02 00072652915TRLO0 XLON
2 December 2024 185 225.50 08:59:29 00072653225TRLO0 XLON
2 December 2024 400 225.50 08:59:29 00072653224TRLO0 XLON
2 December 2024 200 225.50 08:59:29 00072653223TRLO0 XLON
2 December 2024 100 225.50 09:04:29 00072653470TRLO0 XLON
2 December 2024 300 225.50 09:05:14 00072653499TRLO0 XLON
2 December 2024 247 225.50 09:07:12 00072653590TRLO0 XLON
2 December 2024 140 225.50 09:11:02 00072653696TRLO0 XLON
2 December 2024 420 226.50 09:31:08 00072654350TRLO0 XLON
2 December 2024 163 226.50 09:31:08 00072654353TRLO0 XLON
2 December 2024 136 226.50 09:31:08 00072654352TRLO0 XLON
2 December 2024 735 226.50 09:31:08 00072654351TRLO0 XLON
2 December 2024 67 226.50 09:31:08 00072654356TRLO0 XLON
2 December 2024 94 226.50 09:31:08 00072654355TRLO0 XLON
2 December 2024 167 226.50 09:31:08 00072654354TRLO0 XLON
2 December 2024 1155 226.00 09:31:48 00072654385TRLO0 XLON
2 December 2024 1221 226.00 09:31:48 00072654384TRLO0 XLON
2 December 2024 2315 226.00 10:00:23 00072655167TRLO0 XLON
2 December 2024 245 226.00 10:00:23 00072655166TRLO0 XLON
2 December 2024 100 226.00 11:00:59 00072656835TRLO0 XLON
2 December 2024 368 226.00 11:00:59 00072656834TRLO0 XLON
2 December 2024 29 226.00 11:00:59 00072656833TRLO0 XLON
2 December 2024 82 226.00 11:14:00 00072657227TRLO0 XLON
2 December 2024 100 226.00 11:14:00 00072657226TRLO0 XLON
2 December 2024 200 226.00 11:14:00 00072657225TRLO0 XLON
2 December 2024 200 226.00 11:25:00 00072657489TRLO0 XLON
2 December 2024 100 226.00 11:25:00 00072657488TRLO0 XLON
2 December 2024 308 226.00 11:35:25 00072657718TRLO0 XLON
2 December 2024 416 226.00 11:35:25 00072657719TRLO0 XLON
2 December 2024 440 226.00 11:42:00 00072657834TRLO0 XLON
2 December 2024 297 226.00 11:42:00 00072657833TRLO0 XLON
2 December 2024 1 226.00 11:42:00 00072657832TRLO0 XLON
This announcement will also be available on the Company's website at:
https://investors.spirehealthcare.com/news/regulatory-news/
Enquiries:
Spire Healthcare
Harbant Samra, CFO
+44 (0)7881 672 365
Instinctif Partners
Julian
Walker
+44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare (http://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.
Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.
Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSVLLFBZLLLFBQ